Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults

NCT06616922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Conjunctivitis, Bacterial

Interventions

DRUG: RD03/2016 eye drops
DRUG: Levofloxacin 0.5% eye drops solution (Oftaquix®)

Sponsor

NTC srl